Target intelligence / Profile preview

Unconventional myosin-Ia (MYO1A)

Target
MYO1A
Molecular classification
Motor protein, Actin-binding protein, Cytoskeletal protein, Myosin superfamily, Class I myosin
01

Overview

Unconventional myosin-Ia (MYO1A) is a monomeric, actin-based motor protein belonging to the myosin superfamily, specifically the class I myosins[3][5]. MYO1A is most abundantly expressed in enterocytes—the absorptive epithelial cells that line the small intestine—where it localizes to the apical brush border microvilli and plays a critical role in maintaining the tightly organized structure and membrane-cytoskeleton cohesion of this compartment[1][2][3]. Its primary molecular activities include directing membrane-associated organelle movement along actin filaments, contributing to the proper organization of microvillar membranes, and regulating tension and stability of the brush border through its interactions with actin and acidic phospholipids in the membrane[1][2][3][5]. MYO1A contains the conserved N-terminal myosin motor domain (responsible for ATP-driven mechanical movement), a neck region with calmodulin-binding IQ motifs (involved in calcium signaling and stabilization), and a unique C-terminal tail (essential for membrane targeting and protein interactions)[3][2]. Loss of MYO1A disrupts brush border architecture, resulting in defects in microvillar morphology, mislocalization of membrane and cytoskeletal proteins, and functional compensation by related class I myosins, like myosin-1c[1]. Mutations in MYO1A have been linked to diseases such as autosomal dominant non-syndromic hearing loss (DFNA48) and certain forms of congenital diarrhea[5]. There are no known approved drugs, biomarker roles, or safety concerns currently associated with MYO1A, and it is not considered a classical therapeutic target (such as an enzyme, receptor, an ion channel, or transporter), but rather a structural and functional cytoskeletal motor protein[5][3].

Other names
brush border myosin Imyosin I heavy chainMYHLBBM-IBBMIMIHCDFNA48DIAR15myosin, heavy polypeptide-like (100kD)myosin, heavy polypeptide-like 110kDa
02

Biological functions

Organelle transportActin cytoskeleton organizationBrush border morphology maintenanceMembrane-cytoskeleton tetheringMembrane tension regulationVesicular trafficking
03

Disease associations

Genetic deafness (autosomal dominant deafness 48)Congenital diarrhea (diarrhea 15, congenital)Potential involvement in enterocyte/cellular stress responses

Beyond the preview

Go deeper on Unconventional myosin-Ia (MYO1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unconventional myosin-Ia (MYO1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call